61 related articles for article (PubMed ID: 23108622)
1. Autophosphorylation activation and inhibition by curcumin of the epidermal growth factor receptor reconstituted in liposomes.
Doumiati S; Haupt K; Rossi C
J Mol Recognit; 2012 Nov; 25(11):623-9. PubMed ID: 23108622
[TBL] [Abstract][Full Text] [Related]
2. Effect of membrane fluidity on tyrosine kinase activity of reconstituted epidermal growth factor receptor.
Ge G; Wu J; Lin Q
Biochem Biophys Res Commun; 2001 Mar; 282(2):511-4. PubMed ID: 11401489
[TBL] [Abstract][Full Text] [Related]
3. Loss of cytotoxic effect of epidermal growth factor (EGF) on EGF receptor overexpressing cells is associated with attenuation of EGF receptor tyrosine kinase activity.
Gardner DP; Shimizu N
J Cell Physiol; 1994 Feb; 158(2):245-55. PubMed ID: 8106561
[TBL] [Abstract][Full Text] [Related]
4. Modulation of the protein tyrosine kinase activity and autophosphorylation of the epidermal growth factor receptor by its juxtamembrane region.
Poppleton HM; Wiepz GJ; Bertics PJ; Patel TB
Arch Biochem Biophys; 1999 Mar; 363(2):227-36. PubMed ID: 10068444
[TBL] [Abstract][Full Text] [Related]
5. Differential requirement of EGF receptor and its tyrosine kinase for AP-1 transactivation induced by EGF and TPA.
Li J; Ma C; Huang Y; Luo J; Huang C
Oncogene; 2003 Jan; 22(2):211-9. PubMed ID: 12527890
[TBL] [Abstract][Full Text] [Related]
6. Urokinase-induced smooth muscle cell responses require distinct signaling pathways: a role for the epidermal growth factor receptor.
Nicholl SM; Roztocil E; Davies MG
J Vasc Surg; 2005 Apr; 41(4):672-81. PubMed ID: 15874933
[TBL] [Abstract][Full Text] [Related]
7. Anti-epidermal growth factor receptor monoclonal antibodies affecting signal transduction.
Reins HA; Steinhilber G; Freiberg B; Anderer FA
J Cell Biochem; 1993 Feb; 51(2):236-48. PubMed ID: 8382707
[TBL] [Abstract][Full Text] [Related]
8. Blockade of the epidermal growth factor receptor tyrosine kinase activity by quercetin and luteolin leads to growth inhibition and apoptosis of pancreatic tumor cells.
Lee LT; Huang YT; Hwang JJ; Lee PP; Ke FC; Nair MP; Kanadaswam C; Lee MT
Anticancer Res; 2002; 22(3):1615-27. PubMed ID: 12168845
[TBL] [Abstract][Full Text] [Related]
9. Probing homodimer formation of epidermal growth factor receptor by selective crosslinking.
Sun X; Dusserre-Bresson F; Baker B; Zhang A; Xu P; Fibbe C; Noren CJ; CorrĂȘa IR; Xu MQ
Eur J Med Chem; 2014 Dec; 88():34-41. PubMed ID: 25042004
[TBL] [Abstract][Full Text] [Related]
10. Regeneration of human epidermis on acellular dermis is impeded by small-molecule inhibitors of EGF receptor tyrosine kinase.
Forsberg S; Ostman A; Rollman O
Arch Dermatol Res; 2008 Oct; 300(9):505-16. PubMed ID: 18446355
[TBL] [Abstract][Full Text] [Related]
11. Epidermal growth factor receptor in cultured human retinal pigment epithelial cells.
Yan F; Hui YN; Li YJ; Guo CM; Meng H
Ophthalmologica; 2007; 221(4):244-50. PubMed ID: 17579290
[TBL] [Abstract][Full Text] [Related]
12. Curcumin inhibits human colon cancer cell growth by suppressing gene expression of epidermal growth factor receptor through reducing the activity of the transcription factor Egr-1.
Chen A; Xu J; Johnson AC
Oncogene; 2006 Jan; 25(2):278-87. PubMed ID: 16170359
[TBL] [Abstract][Full Text] [Related]
13. Electrostatic interactions of peptides flanking the tyrosine kinase domain in the epidermal growth factor receptor provides a model for intracellular dimerization and autophosphorylation.
Aifa S; Miled N; Frikha F; Aniba MR; Svensson SP; Rebai A
Proteins; 2006 Mar; 62(4):1036-43. PubMed ID: 16380971
[TBL] [Abstract][Full Text] [Related]
14. Grb2 regulates Stat3 activation negatively in epidermal growth factor signalling.
Zhang T; Ma J; Cao X
Biochem J; 2003 Dec; 376(Pt 2):457-64. PubMed ID: 14498832
[TBL] [Abstract][Full Text] [Related]
15. EGFR activation coupled to inhibition of tyrosine phosphatases causes lateral signal propagation.
Reynolds AR; Tischer C; Verveer PJ; Rocks O; Bastiaens PI
Nat Cell Biol; 2003 May; 5(5):447-53. PubMed ID: 12717446
[TBL] [Abstract][Full Text] [Related]
16. Epidermal growth factor receptor regulates osteoclast differentiation and survival through cross-talking with RANK signaling.
Yi T; Lee HL; Cha JH; Ko SI; Kim HJ; Shin HI; Woo KM; Ryoo HM; Kim GS; Baek JH
J Cell Physiol; 2008 Nov; 217(2):409-22. PubMed ID: 18543257
[TBL] [Abstract][Full Text] [Related]
17. Unique role of SNT-2/FRS2beta/FRS3 docking/adaptor protein for negative regulation in EGF receptor tyrosine kinase signaling pathways.
Huang L; Watanabe M; Chikamori M; Kido Y; Yamamoto T; Shibuya M; Gotoh N; Tsuchida N
Oncogene; 2006 Oct; 25(49):6457-66. PubMed ID: 16702953
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of platelet-derived growth factor and epidermal growth factor receptor signaling events after treatment of cells with specific synthetic inhibitors of tyrosine kinase phosphorylation.
Lipson KE; Pang L; Huber LJ; Chen H; Tsai JM; Hirth P; Gazit A; Levitzki A; McMahon G
J Pharmacol Exp Ther; 1998 May; 285(2):844-52. PubMed ID: 9580635
[TBL] [Abstract][Full Text] [Related]
19. Diversification of Neu differentiation factor and epidermal growth factor signaling by combinatorial receptor interactions.
Pinkas-Kramarski R; Soussan L; Waterman H; Levkowitz G; Alroy I; Klapper L; Lavi S; Seger R; Ratzkin BJ; Sela M; Yarden Y
EMBO J; 1996 May; 15(10):2452-67. PubMed ID: 8665853
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of growth factor-mediated tyrosine phosphorylation in vascular smooth muscle by PD 089828, a new synthetic protein tyrosine kinase inhibitor.
Dahring TK; Lu GH; Hamby JM; Batley BL; Kraker AJ; Panek RL
J Pharmacol Exp Ther; 1997 Jun; 281(3):1446-56. PubMed ID: 9190882
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]